LONG TERM SAFETY AND EFFICACY OF BIOSIMILAR INFLIXIMAB AMONG PATIENTS WITH INFLAMMATORY ARTHRITIS SWITCHED FROM REFERENCE PRODUCT

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputOther Item
Volume75
DOIs
Publication statusPublished - 1 Jun 2016

Cite this